Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation

Autor: J. David Burkhardt, Patrick Müller, Sanghamitra Mohanty, Phillipp Halbfaß, Carola Gianni, Rodney Horton, Gery Tomassoni, Chintan Trivedi, Anja Schade, Amin Al-Ahmad, Andrea Natale, Thomas Deneke, G. Joseph Gallinghouse, Rong Bai, Patrick Hranitzky, Yalçın Gökoğlan, Javier Sanchez, Mahmut F. Güneş, Tamara Metz, Luigi Di Biase
Rok vydání: 2016
Předmět:
Male
medicine.medical_specialty
Time Factors
medicine.medical_treatment
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
Catheter ablation
030204 cardiovascular system & hematology
03 medical and health sciences
Imaging
Three-Dimensional

Postoperative Complications
0302 clinical medicine
Heart Conduction System
Physiology (medical)
Internal medicine
Atrial Fibrillation
Humans
Medicine
In patient
Prospective Studies
030212 general & internal medicine
Prospective cohort study
Adverse effect
Atrial tachycardia
business.industry
Incidence
Body Surface Potential Mapping
Atrial fibrillation
Equipment Design
Middle Aged
medicine.disease
Ablation
United States
Europe
Treatment Outcome
Catheter Ablation
Cardiology
Female
Electrical conduction system of the heart
medicine.symptom
Cardiology and Cardiovascular Medicine
business
Follow-Up Studies
Zdroj: Heart Rhythm. 13:830-835
ISSN: 1547-5271
Popis: Background Focal impulse and rotor modulation (FIRM)-guided ablation targets sites that are thought to sustain atrial fibrillation (AF). Objective The purpose of this study was to evaluate the acute and mid-term outcomes of FIRM-guided only ablation in patients with nonparoxysmal AF. Methods We prospectively enrolled patients with persistent and long-standing persistent (LSP) AF at three centers to undergo FIRM-guided only ablation. We evaluated acute procedural success (defined as AF termination, organization, or ≥10% slowing), safety (incidence of periprocedural complications), and long-term success (single-procedure freedom from atrial tachycardia [AT]/AF off antiarrhythmic drugs [AAD] after a 2-month blanking period). Results Twenty-nine patients with persistent (N = 20) and LSP (N = 9) AF underwent FIRM mapping. Rotors were presents in all patients, with a mean of 4 ± 1.2 per patient (62% were left atrial); 1 focal impulse was identified. All sources were successfully ablated, and overall acute success rate was 41% (0 AF termination, 2 AF slowing, 10 AF organization). There were no major procedure-related adverse events. After a mean 5.7 months of follow-up, single-procedure freedom from AT/AF without AADs was 17%. Conclusion In nonparoxysmal AF patients, targeted ablation of FIRM-identified rotors is not effective in obtaining AF termination, organization, or slowing during the procedure. After mid-term follow-up, the strategy of ablating FIRM-identified rotors alone did not prevent recurrence from AT/AF.
Databáze: OpenAIRE